Smithfield Foods introduces Smithfield Bioscience to leverage byproducts from the meat production process
Today, Smithfield sells byproducts to pharmaceutical and nutraceutical companies to develop drugs that treat a range of issues.
Smithfield Foods, Inc., Smithfield, Va., launched Smithfield Bioscience, a new strategic platform within the organization that leverages byproducts from the meat production process for the development of pharmaceuticals, nutraceuticals and medical device solutions.
"Our commitment to innovation and sustainability stretches across all aspects of our company," says Kenneth Sullivan, president and CEO. "Smithfield Bioscience reflects these same values by finding new uses for byproducts that benefit the health and well-being of others."